Diabetes / Glucose Control:
Pola P, "Composition for the prevention and/or treatment of lipid metabolism disorders and allergic forms," U.S. Patent Application 20030017999, January 23, 2003.
Direct Quote: ".beta-1,3-D-glucan has proved effective not only in preventing lipid metabolism disorders, but also in stimulating immune defenses, in preventing onset of tumors and in controlling serum glucose.” Carrow, D.J.; “Beta-1,3-glucan as a Primary Immune Activator,”
Townsend Letter; June 1996.
Direct Quote: “The following list includes benefits from the use of Beta 1,3-glucan supplementation: …people with chronic degenerative disorders such as diabetes or chronic inflammation. …”
Kida K., Inoue T., et al; “An immunopotentiator of beta-1,6;1,3 D-glucan prevents diabetes and insulitis in BB rats.” Diabetes. Res. Clin. Pract. 17:75-79. 1992.
Direct Quote: “The preventive effect of an immunopotentiator, beta-1,6;1,3 D-glucan, on the development of diabetes and insulitis was studied in BB rats….[and] decreased the cumulative incidence of diabetes from 43.3% to 6.7% and also the incidence of insulitis from 82.4% to 26.3%….These data indicate that immunopotentiators could modulate the autoimmune mechanisms directed to pancreatic islets and inhibit the development of diabetes in BB rats.”
ClinicalImmunity.com © 2008